Jenith
Well-known Member
- Joined
- Mar 25, 2019
- Posts
- 54,065
- Likes
- 246
GLP-1 drugs have become quite popular for weight loss. They're available as both injectable and oral treatments. As more and more people begin GLP-1 weight loss therapy, medical research is now focused on mitigating the potential for muscle loss.
To that end, Samsung has launched a joint study with the Massachusetts General Hospital to monitor muscle loss in patients using GLP-1 medications with the help of the Galaxy Watch 8.
The study will look into the potential for the Galaxy Watch in helping adults starting GLP-1 treatments to monitor and potentially manage muscle loss resulting from their treatment.
Nearly one in five adults in the United States have said that they've taken GLP-1 medication. This study aims to figure out if continuous data from the Galaxy Watch can help both patients and their doctors monitor and mitigate muscle loss.
This study will utilize biometric data obtained from the Galaxy Watch 8 including activity levels, body composition, and heart rate. 100 adults will be enrolled in this study, split into two groups. The first will use the Galaxy Watch to monitor their body composition while they're on the medication while the other group will only receive the standard guidance provided to patients starting GLP-1 therapy.
Researchers will also use clinical-grade DXA scans to track body composition changes in both groups to determine whether insights provided by the Galaxy Watch 8 can help support users to achieve better health outcomes, including preservation of muscle mass.
This isn't the first time that Samsung is teaming up with Massachusetts General Hospital for a study powered by the Galaxy Watch. The two have previously worked together to determine how to best use the biometric data from the Galaxy Watch to support better mental health outcomes.
To that end, Samsung has launched a joint study with the Massachusetts General Hospital to monitor muscle loss in patients using GLP-1 medications with the help of the Galaxy Watch 8.
100 adults will participate in this study
The study will look into the potential for the Galaxy Watch in helping adults starting GLP-1 treatments to monitor and potentially manage muscle loss resulting from their treatment.
Nearly one in five adults in the United States have said that they've taken GLP-1 medication. This study aims to figure out if continuous data from the Galaxy Watch can help both patients and their doctors monitor and mitigate muscle loss.
This study will utilize biometric data obtained from the Galaxy Watch 8 including activity levels, body composition, and heart rate. 100 adults will be enrolled in this study, split into two groups. The first will use the Galaxy Watch to monitor their body composition while they're on the medication while the other group will only receive the standard guidance provided to patients starting GLP-1 therapy.
Researchers will also use clinical-grade DXA scans to track body composition changes in both groups to determine whether insights provided by the Galaxy Watch 8 can help support users to achieve better health outcomes, including preservation of muscle mass.
This isn't the first time that Samsung is teaming up with Massachusetts General Hospital for a study powered by the Galaxy Watch. The two have previously worked together to determine how to best use the biometric data from the Galaxy Watch to support better mental health outcomes.